Anthony Harrelson: Using RNA Interference to Stop Infectious Diseases

Anthony Harrelson is a leader in the field of biopharmaceutical technology, and is dedicated to making the world a better place by stopping the spread of infectious, deadly diseases. He is currently serving as the Chief Executive Officer and Founder of White Oak Industries Inc., which is a biopharmaceutical company that is tasked with creating vaccines for diseases like HIV and Ebola. He holds a PhD in Microbiology, as well as a Master of Business Administration degree in Finance. He understands how to run a successful company in a competitive industry, and he also understands the biopharmaceutical world as well. Using the latest advancements in biotechnology, he is equipped to stop the spread of some of the most deadly diseases in the world.

Anthony Harrelson’s approach to fighting infectious diseases is to use the power of the body’s own immune system to kill any disease its source. By using what is called RNA interference, he can develop customized immunotherapies that employ a response in the patient’s own immune system. Through the use of the patient’s dendritic cells, and stem cell technology, the immune system will be capable of destroying the specific disease infecting their body before it can spread and mutate in the next host. This kind of approach is not only unique, but it has also never been attempted before.

RNA interference is considered one of the most important discoveries in the last decade in terms of biopharmaceutical technology. RNA interference has the power to give rise to a whole new class of therapies to active the body’s own natural processes. It has the ability to eliminate disease-causing proteins at the cellular level, which is not something that has been achievable through the use of modern drugs. White Oak Industries Inc. is the leader in RNA interference based immunotherapies, and they are proud to enter into markets that are suffering from a lack of medical expertise.

Anthony Harrelson and White Oak Industries Inc. are dedicated to stopping some of the world’s most deadly and infectious diseases such as HIV. They believe that through their unique approach to therapy and RNA interference, they will be able to stop diseases at their source before they can spread and ultimately mutate. They have found that dendritic cells act as a switch that turns the immune system on or off because they can recognize foreign bodies infecting the body itself. They activate the body’s response to fighting these foreign bodies, and through stem cell technology, they can receive the support they need to stop the infection. They are the key to modern immunotherapies, and White Oak Industries Inc. will use them to help people all over the world.